Newsroom | 5858 results

TREASURE BEACH, Jamaica--(BUSINESS WIRE)--Psychedelic therapy has a continuity-of-care problem. People often pursue treatment outside their existing mental health care, leaving their therapists disconnected from potentially significant therapeutic experiences. MycoMeditations is working to change that with the Bridge, a new program designed to connect clients’ existing mental health practitioners with the clinical team delivering their psilocybin-assisted therapy in Jamaica. “The person who kno...

韩国首尔--(BUSINESS WIRE)--(美国商业资讯)-- 第14届国际人参研讨会（The Korean Society of Ginseng主办）公布的多项临床与临床前研究表明，红参（Panax ginsengC.A. Meyer）对改善与年龄相关的生理功能衰退具有多方面的作用。相关研究结果涵盖了氧化应激调节、睡眠质量、认知功能衰退、代谢功能障碍以及肌肉功能等多个领域。 由上海交通大学医学院Hong-Sheng Tan教授领导的研究团队，对900名40至75岁自述存在慢性疲劳及免疫功能受损、但无明显器质性疾病的中国成年人进行了评估，旨在评估补充红参对抗氧化能力和整体健康状况的影响。研究显示，作为脂质过氧化及氧化应激生物标志物的血清丙二醛（MDA）水平，在红参组中显著下降，而在安慰剂组中则有所上升。其中，40至60岁受试者的抗氧化作用最为显著，且抗氧化能力与氧化应激水平呈负相关。 在经验证的健康相关生活质量评估工具——36项简明健康状况调查表（SF-36）的八个维度中，红参组的平均得分提高了10.68分，而安慰剂组仅提高了7.13分。其中，在“生理职能”和“活力”两个维度上，两...

韓国ソウル--(BUSINESS WIRE)--（ビジネスワイヤ） -- 第14回国際人参シンポジウム（主催：韓国高麗人参学会）で発表された臨床試験および前臨床試験によると、紅参（Panax ginseng C.A. Meyer）は加齢に伴う生理機能の低下に対して多面的な効果を発揮することが報告されました。その研究結果は、酸化ストレスの調節、睡眠の質、認知機能の低下、代謝機能障害、および筋肉の機能にまで及んでいました。 上海交通大学医学院のホンシェン・タン教授が率いる研究チームは、明らかな器質的疾患はみられないものの、慢性疲労や免疫機能の低下を訴える40歳から75歳の中国人900人を対象に、紅参の摂取が抗酸化能および健康状態に与える影響を評価しました。脂質過酸化反応および酸化ストレスのバイオマーカーである血清マロンジアルデヒド（MDA）は、紅参群では有意に減少した一方、プラセボ群では増加しました。抗酸化作用は40～60歳の参加者で最も顕著にみられ、抗酸化能と酸化ストレスレベルの間には逆相関が認められました。 健康関連の生活の質（QOL）を測定する妥当性が確認された尺度である「Shor...

SEOUL, South Korea--(BUSINESS WIRE)--At the 14th International Symposium on Ginseng, THE Korean Society of Ginseng presented research on red ginseng's anti-aging and cognitive benefits....

NEW YORK--(BUSINESS WIRE)--Definium Therapeutics, Inc. (NASDAQ: DFTX), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes of psychiatric and neurological disorders, today announced that it will host a webcast at 4:30 p.m. EST on Monday, November 9, 2026 to report financial results for the third quarter ended September 30, 2026, and discuss recent business highlights.Listeners can register for the webcast via this link...

SUMMIT, N.J.--(BUSINESS WIRE)--On Monday, November 16, leading medical aesthetics brand, JECT, is opening the doors to its tenth location in Summit, New Jersey. From New York to Los Angeles to Miami, JECT was founded in 2019 by Gabby Garritano, PA-C, and was built on a simple idea: expert providers, personalized treatment plans, and a modern approach to medical aesthetics. “When I founded JECT in 2019, I wanted to create a place where medical aesthetics felt modern, personal, and truly welcomin...

FLORHAM PARK, N.J. & SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Celularity Inc. (Nasdaq: CELU) (“Celularity”), a longevity-focused regenerative and cellular medicine company, and Vesalius Longevity Labs Inc. (“Vesalius”), a leading, global peptide and longevity brand, today announced that they have entered into an exclusive manufacturing agreement to establish a dedicated, first-of-its-kind, U.S. final stage API manufacturing and supply platform for Vesalius’s Peptual-branded active pharmaceutical ing...

DALLAS--(BUSINESS WIRE)--Eighty-seven percent of Americans say successful weight management requires support before, during and after weight loss. Yet only 1 in 4 of Americans with employer-sponsored benefits who recently pursued weight loss received ongoing support to help maintain it. These findings come from a national survey conducted by The Harris Poll on behalf of Wondr Health, the leading provider of preventive weight and GLP-1 management solutions. Employers have expanded access to weig...

SMITHS FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation (“Canopy Growth”, “our”, “we” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a leading global company committed to bettering lives through cannabis, today announced the voting results from its annual general and special meeting of shareholders convened on September 25, 2026, and adjourned to and reconvened on October 23, 2026 (the “Meeting”). A total of 154,837,897 common shares of the Company (the “Shares”), representing 36.60% of...

SMITHS FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation (“Canopy Growth”, “our”, “we” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a leading global company committed to bettering lives through cannabis, will release its financial results for the second quarter fiscal year 2027 ended September 30, 2026, before financial markets open on November 6, 2026. Following the release of its financial results, Canopy Growth will host an audio webcast with Luc Mongeau, CEO, and Tom Stewart, CFO,...